Product Information
METHYLDOPA 250 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $7.4999 per EA under NDC 64980057101. Its NADAC has been published 44 times since Aug 27, 2025.
Strength
250 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980057101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
8/27/2025
Active Ingredients
METHYLDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA070076On Market Since
4/4/2025
Pharmacological Classes
Price Statistics
The NADAC for METHYLDOPA 250 MG TABLET has been published 44 times since Aug 27, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.4999 per EA |
|---|---|
| All-time high | $7.4999 (Jun 24, 2026) |
| All-time low | $7.4999 (Aug 27, 2025) |
| 52-week high | $7.4999 |
| 52-week low | $7.4999 |
| Median price | $7.4999 |
| Average price | $7.4999 |
| Largest weekly change | 0.0% (Sep 3, 2025) |
| Weeks tracked | 44 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the methyldopa market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of METHYLDOPA 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLDOPA 250 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $7.4999 per EA (NDC 64980057101), effective Jun 24, 2026.
How has the price of METHYLDOPA 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLDOPA 250 MG TABLET has held within roughly two percent of its current level. It has been tracked across 44 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for METHYLDOPA 250 MG TABLET?
Since Aug 27, 2025, the NADAC for METHYLDOPA 250 MG TABLET has ranged from a low of $7.4999 (Aug 27, 2025) to a high of $7.4999 (Jun 24, 2026), with a median of $7.4999 per EA.
Are there cheaper alternatives to METHYLDOPA 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of METHYLDOPA 250 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures METHYLDOPA 250 MG TABLET?
METHYLDOPA 250 MG TABLET (NDC 64980057101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification